AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30985571 — intervention group
Group type: COMPARATOR
Intervention: No Modic changes (non-MCs) group
Number of subjects: 204
Study 28474361 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Consultation (VC)
Number of subjects: 70
Study 28474361 — intervention group
Group type: COMPARATOR
Intervention: Face-to-Face (F2F)
Number of subjects: 70
Study 26907485 — intervention group
Group type: EXPERIMENTAL
Intervention: Written educational material (intervention group, n=28)
Number of subjects: 83
Study 26907485 — intervention group
Group type: COMPARATOR
Intervention: Biopsy only group (n=25)
Number of subjects: 83
Study 26907485 — intervention group
Group type: COMPARATOR
Intervention: Control group without biopsy (n=30)
Number of subjects: 83
Study 25040799 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TA) 3 g a day
Number of subjects: 118
Study 25040799 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study 23140829 — intervention group
Group type: EXPERIMENTAL
Intervention: Transanal hemorrhoidal dearterialization (THD)
Number of subjects: 114
Study 23140829 — intervention group
Group type: COMPARATOR
Intervention: LigaSure
Number of subjects: 114
Study 20109864 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation and an ICD (ablation group)
Number of subjects: 110
Study 20109864 — intervention group
Group type: COMPARATOR
Intervention: ICD alone (control group)
Number of subjects: 110
Study 18006568 — intervention group
Group type: EXPERIMENTAL
Intervention: BiliMed (Medick SA, Paris, France)
Number of subjects: 686
Study 18006568 — intervention group
Group type: COMPARATOR
Intervention: BiliCheck (Respironics, Marietta, GA, USA)
Number of subjects: 686
Study 16100174 — intervention group
Group type: EXPERIMENTAL
Intervention: nCPAP (10 cm H2O for 12 to 24 h)
Number of subjects: 56
Study 16100174 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (intermittent nCPAP 10 cm H2O for 10 min every 4 h)
Number of subjects: 56
Study 12052996 — intervention group
Group type: EXPERIMENTAL
Intervention: Coupled protocol of EMG-triggered stimulation and bilateral movement (n=10)
Number of subjects: 25
Study 12052996 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG-triggered stimulation and unilateral movement (n=10)
Number of subjects: 25
Study 12052996 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=5)
Number of subjects: 25
Study 10598196 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted parathyroidectomy (VAP)
Number of subjects: 38
Study 10598196 — intervention group
Group type: COMPARATOR
Intervention: Conventional cervicotomy
Number of subjects: 38
Study 8583185 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine breast screening with mammograms and physical examination
Number of subjects: 0
Study 8583185 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine breast screening with mammography and physical examination
Number of subjects: 0
Study 1755531 — intervention group
Group type: EXPERIMENTAL
Intervention: NLA in combination with epidural opiate analgesia (group 2)
Number of subjects: 28
Study 1755531 — intervention group
Group type: EXPERIMENTAL
Intervention: NLA in combination with local anesthesia (group 3)
Number of subjects: 28
Study 1755531 — intervention group
Group type: COMPARATOR
Intervention: Neuroleptanesthesia (NLA) (group 1)
Number of subjects: 28
Study 1755531 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidurally administered morphine (group 2)
Number of subjects: 28
Study 1755531 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural local anesthetics (group 3)
Number of subjects: 28
Study 6804222 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg DPM (dipropylacetamide) taken after a standard meal
Number of subjects: 6
Study 6804222 — intervention group
Group type: COMPARATOR
Intervention: 60 mg DPM (dipropylacetamide) taken in a fasting state
Number of subjects: 6
Study 31038276 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemostatic sealant
Number of subjects: 94
Study 31038276 — intervention group
Group type: COMPARATOR
Intervention: Standard care (bipolar coagulation)
Number of subjects: 94
Study 28716313 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine (myIBDcoach)
Number of subjects: 909
Study 28716313 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 909
Study 25620717 — intervention group
Group type: EXPERIMENTAL
Intervention: Servomatic A and B
Number of subjects: 52
Study 25620717 — intervention group
Group type: EXPERIMENTAL
Intervention: E‐motion
Number of subjects: 52
Study 25620717 — intervention group
Group type: COMPARATOR
Intervention: Pushrim-activated power-assisted wheelchairs (PAPAWs)
Number of subjects: 52
Study 25042182 — intervention group
Group type: EXPERIMENTAL
Intervention: Ataluren 10, 10, 20 mg/kg
Number of subjects: 174
Study 25042182 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 174
Study 22550833 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose pantoprazole bolus injections (40 mg twice daily for 7 days)
Number of subjects: 28
Study 22550833 — intervention group
Group type: COMPARATOR
Intervention: Continuous intravenous infusion of pantoprazole (8 mg per hour for first 3 days, then 40 mg bolus twice daily for 4-7 days)
Number of subjects: 28
Study 22550833 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose pantoprazole bolus injections
Number of subjects: 28
Study 22550833 — intervention group
Group type: COMPARATOR
Intervention: Continuous intravenous infusion of pantoprazole
Number of subjects: 28
Study 22550833 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 28
Study 19961732 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole (201)Tl SPECT myocardial imaging (group 1, n = 35)
Number of subjects: 63
Study 19961732 — intervention group
Group type: COMPARATOR
Intervention: Exercise myocardial (99)Tc(m)-MIBI SPECT imaging (group 2, n = 28)
Number of subjects: 63
Study 17086540 — intervention group
Group type: EXPERIMENTAL
Intervention: Dysfunctional Attitude Scale (DAS) scores at the beginning of the continuation phase
Number of subjects: 64
Study 17086540 — intervention group
Group type: EXPERIMENTAL
Intervention: Dysfunctional Attitude Scale (DAS) scores at the beginning of continuation treatment
Number of subjects: 64
Study 15022126 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily 2.5-mg rhDNase
Number of subjects: 48
Study 15022126 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate-day 2.5-mg rhDNase
Number of subjects: 48
Study 15022126 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily 5 ml of 7% hypertonic saline (HS)
Number of subjects: 48
Study 15022126 — intervention group
Group type: COMPARATOR
Intervention: Baseline characteristics
Number of subjects: 48
Study 11265078 — intervention group
Group type: EXPERIMENTAL
Intervention: Color duplex ultrasound (CDU)
Number of subjects: 41
Study 11265078 — intervention group
Group type: COMPARATOR
Intervention: CT scanning
Number of subjects: 41
Study 9772930 — intervention group
Group type: EXPERIMENTAL
Intervention: Benazepril 10 mg once daily for 8 weeks
Number of subjects: 16987
Study 9772930 — intervention group
Group type: EXPERIMENTAL
Intervention: Benazepril 10 mg once daily for 4 weeks, then Hydrochlorothiazide 12.5 mg once daily for the last 4 weeks if DBP > 90 mmHg
Number of subjects: 16987
Study 9772930 — intervention group
Group type: EXPERIMENTAL
Intervention: Benazepril alone or associated with Hydrochlorothiazide
Number of subjects: 16987
Study 8170729 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP-T with diphtheria toxoid vaccine
Number of subjects: 146
Study 8170729 — intervention group
Group type: COMPARATOR
Intervention: PRP-OMP with diphtheria-tetanus toxoid vaccine
Number of subjects: 146
Study 8170729 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP-T
Number of subjects: 146
Study 8170729 — intervention group
Group type: COMPARATOR
Intervention: PRP-OMP
Number of subjects: 146
Study 8170729 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphtheria-tetanus toxoid vaccine
Number of subjects: 146
Study 3336263 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenoidectomy
Number of subjects: 476
Study 3336263 — intervention group
Group type: EXPERIMENTAL
Intervention: Both adenoidectomy and tympanostomy tubes
Number of subjects: 476
Study 3336263 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 476
Study 3336263 — intervention group
Group type: COMPARATOR
Intervention: Tympanostomy tubes
Number of subjects: 476
Study 30709606 — intervention group
Group type: EXPERIMENTAL
Intervention: Head of Bed Elevation (HBE) at 30° for 20 minutes
Number of subjects: 0
Study 30709606 — intervention group
Group type: EXPERIMENTAL
Intervention: Head of Bed Elevation (HBE) at 45° for 20 minutes
Number of subjects: 0
Study 30709606 — intervention group
Group type: COMPARATOR
Intervention: Cervical collar (c-collar)
Number of subjects: 0
Study 29132380 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard government guidance with active enhancement of TB-HIV care integration through a quality improvement approach
Number of subjects: 40
Study 29132380 — intervention group
Group type: COMPARATOR
Intervention: Standard government guidance for TB-HIV integration
Number of subjects: 40
Study 26601519 — intervention group
Group type: EXPERIMENTAL
Intervention: cytoflavin during operation and in early postoperative period
Number of subjects: 90
Study 24169352 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy (SLNB)
Number of subjects: 518
Study 24169352 — intervention group
Group type: COMPARATOR
Intervention: Axillary lymph node dissection (ALND)
Number of subjects: 518
Study 24169352 — intervention group
Group type: COMPARATOR
Intervention: SLNB followed by ALND
Number of subjects: 518
Study 20603243 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of Life Therapy (QOLT)
Number of subjects: 62
Study 20603243 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive Therapy (ST)
Number of subjects: 62
Study 20603243 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 62
Study 19047882 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic Self Report Assessment‐Cancer (ESRA‐C) program on wireless laptops with touch-screen format
Number of subjects: 342
Study 19047882 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic Self Report Assessment‐Cancer (ESRA‐C) program
Number of subjects: 342
Study 17023243 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerometry monitoring of arm activity
Number of subjects: 169
Study 17023243 — intervention group
Group type: EXPERIMENTAL
Intervention: Actual Amount of Use Test (AAUT)
Number of subjects: 169
Study 17023243 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Activity Log (MAL)
Number of subjects: 169
Study 12787692 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% oxygen (treatment group)
Number of subjects: 18
Study 12787692 — intervention group
Group type: COMPARATOR
Intervention: Air (control group)
Number of subjects: 18
Study 12579906 — intervention group
Group type: EXPERIMENTAL
Intervention: Shunt tube implantation combining amniotic membrane transplantation
Number of subjects: 41
Study 12579906 — intervention group
Group type: EXPERIMENTAL
Intervention: Shunt tube with amniotic supporter and amniotic membrane transplantation
Number of subjects: 41
Study 12579906 — intervention group
Group type: COMPARATOR
Intervention: Single plate Molteno implant
Number of subjects: 41
Study 8672373 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl preloaded bypass pump
Number of subjects: 0
Study 8672373 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline preloaded bypass pump
Number of subjects: 0
Study 1794303 — intervention group
Group type: EXPERIMENTAL
Intervention: Lyophilized type I collagen (LC)
Number of subjects: 20
Study 1794303 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic acid medicated gauze
Number of subjects: 20
Study 6387183 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-day treatment regimen
Number of subjects: 58
Study 6387183 — intervention group
Group type: COMPARATOR
Intervention: 10-day treatment regimen
Number of subjects: 58
Study 3955903 — intervention group
Group type: EXPERIMENTAL
Intervention: More frequent clinical follow-ups (once a month)
Number of subjects: 17
Study 3955903 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved blood pressure control
Number of subjects: 17
Study 31432723 — intervention group
Group type: EXPERIMENTAL
Intervention: RSVH infants
Number of subjects: 1000000
Study 31432723 — intervention group
Group type: EXPERIMENTAL
Intervention: UBH infants
Number of subjects: 1000000
Study 31432723 — intervention group
Group type: COMPARATOR
Intervention: Comparator infants
Number of subjects: 1000000
Study 30065275 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous vagus nerve stimulation (tVNS)
Number of subjects: 85
Study 30065275 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 85
Study 27599622 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Control Exercise (MCE)
Number of subjects: 36
Study 27599622 — intervention group
Group type: COMPARATOR
Intervention: Stretching Exercise (SE)
Number of subjects: 36
Study 24680372 — intervention group
Group type: EXPERIMENTAL
Intervention: Suvorexant (40 mg for patients younger than 65 years, 30 mg for patients aged 65 years or older)
Number of subjects: 781
Study 24680372 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 781
Study 24680372 — intervention group
Group type: EXPERIMENTAL
Intervention: Suvorexant
Number of subjects: 781
Study 22508924 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 S's (swaddling, side/stomach position, shushing, swinging, and sucking)
Number of subjects: 230
Study 22508924 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 S's with sucrose (24% oral sucrose)
Number of subjects: 230
Study 22508924 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose alone (2 mL of 24% oral sucrose)
Number of subjects: 230
Study 22508924 — intervention group
Group type: COMPARATOR
Intervention: Control (2 mL of water with standard-of-care comfort measures)
Number of subjects: 230
Study 20820114 — intervention group
Group type: EXPERIMENTAL
Intervention: Special mouth care with essential oil (geranium, lavender, tea tree, and peppermint) applied twice daily for one week
Number of subjects: 43
Study 20820114 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline mouth care applied twice daily for one week
Number of subjects: 43
Study 20820114 — intervention group
Group type: EXPERIMENTAL
Intervention: Special mouth care with essential oil
Number of subjects: 43
Study 20820114 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline mouth care
Number of subjects: 43
Study 18210330 — intervention group
Group type: EXPERIMENTAL
Intervention: tibolone 2.5 mg daily for 16 weeks
Number of subjects: 45
Study 18210330 — intervention group
Group type: EXPERIMENTAL
Intervention: 17beta-estradiol 2 mg daily for 16 weeks
Number of subjects: 45
Study 18210330 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hormone therapy)
Number of subjects: 45
Study 15665181 — intervention group
Group type: EXPERIMENTAL
Intervention: Comminuted chicken diet with Benefiber (study diet)
Number of subjects: 116
Study 15665181 — intervention group
Group type: COMPARATOR
Intervention: Comminuted chicken diet without Benefiber (control diet)
Number of subjects: 116
Study 12682324 — intervention group
Group type: COMPARATOR
Intervention: Normalized cortical volumes (NCV) in RR MS patients
Number of subjects: 0
Study 12682324 — intervention group
Group type: COMPARATOR
Intervention: Normalized cortical volumes (NCV) in PP MS patients
Number of subjects: 0
Study 12682324 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of NCV with Expanded Disability Status Scale scores in PP MS patients
Number of subjects: 0
Study 12682324 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of NCV with Expanded Disability Status Scale scores in RR MS patients
Number of subjects: 0
Study 12682324 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of NCV with T2-weighted lesion volume in RR MS patients
Number of subjects: 0
Study 12682324 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of NCV with disease duration in RR MS patients
Number of subjects: 0
Study 10608480 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril and indapamide (for those without contraindications)
Number of subjects: 6105
Study 10608480 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril alone
Number of subjects: 6105
Study 10608480 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6105
Study 9012161 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy for insomnia (IPT‐I)
Number of subjects: 25
Study 9012161 — intervention group
Group type: COMPARATOR
Intervention: Progressive relaxation training (PR)
Number of subjects: 25
Study 1667334 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen (10 mg PO at 0830h)
Number of subjects: 19
Study 1667334 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 1667334 — intervention group
Group type: COMPARATOR
Intervention: Comparison of GH response
Number of subjects: 19
Study 6406531 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphate therapy (8.5 mmol/h or approximately 6 g phosphate/24 h)
Number of subjects: 30
Study 6406531 — intervention group
Group type: COMPARATOR
Intervention: No phosphate therapy (control group)
Number of subjects: 30
Study 31747951 — intervention group
Group type: EXPERIMENTAL
Intervention: PedAMINES app
Number of subjects: 120
Study 31747951 — intervention group
Group type: COMPARATOR
Intervention: Conventional calculation methods
Number of subjects: 120
Study 29553785 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 59
Study 29553785 — intervention group
Group type: EXPERIMENTAL
Intervention: HADS-Depression
Number of subjects: 59
Study 29553785 — intervention group
Group type: EXPERIMENTAL
Intervention: MSWS-12
Number of subjects: 59
Study 29553785 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety
Number of subjects: 59
Study 26992841 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.3-mg injections
Number of subjects: 681
Study 26992841 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.5-mg injections
Number of subjects: 681
Study 26992841 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab (both dosages)
Number of subjects: 681
Study 26992841 — intervention group
Group type: COMPARATOR
Intervention: Sham injections
Number of subjects: 681
Study 24708645 — intervention group
Group type: EXPERIMENTAL
Intervention: First-line antiretroviral therapy (ART)
Number of subjects: 265
Study 24708645 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline genotyping for HIV drug resistance (HIVDR)
Number of subjects: 265
Study 23067427 — intervention group
Group type: EXPERIMENTAL
Intervention: Full CPT protocol (n = 44)
Number of subjects: 126
Study 23067427 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy component of CPT (n = 39)
Number of subjects: 126
Study 23067427 — intervention group
Group type: EXPERIMENTAL
Intervention: Written account component of CPT (n = 43)
Number of subjects: 126
Study 20450930 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative skin cancer message
Number of subjects: 230
Study 20450930 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-narrative skin cancer message
Number of subjects: 230
Study 20450930 — intervention group
Group type: COMPARATOR
Intervention: No-message control condition
Number of subjects: 230
Study 18630541 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifting-thrusting group (n = 37)
Number of subjects: 107
Study 18630541 — intervention group
Group type: COMPARATOR
Intervention: Twirling group (n = 36)
Number of subjects: 107
Study 18630541 — intervention group
Group type: COMPARATOR
Intervention: Routine needling group (n = 34)
Number of subjects: 107
Study 16160130 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents (n = 577)
Number of subjects: 1156
Study 16160130 — intervention group
Group type: COMPARATOR
Intervention: Bare metal stents (n = 579)
Number of subjects: 1156
Study 11454122 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral estrogen (0.625 mg) combined with progesterone (2.5 mg)
Number of subjects: 32
Study 11454122 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 9548613 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole, amoxicillin, and clarithromycin triple therapy
Number of subjects: 0
Study 9548613 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8047821 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of amoxycillin (3 g daily), metronidazole (1 g daily), and omeprazole (20 mg daily)
Number of subjects: 73
Study 8047821 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole alone
Number of subjects: 73
Study 2738215 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-session skills-training program
Number of subjects: 744
Study 2738215 — intervention group
Group type: COMPARATOR
Intervention: Three-session discussion control condition
Number of subjects: 744
Study 2738215 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control condition
Number of subjects: 744
Study 1100789 — intervention group
Group type: EXPERIMENTAL
Intervention: Metrizamide
Number of subjects: 86
Study 1100789 — intervention group
Group type: EXPERIMENTAL
Intervention: Meglumine iocarmate (Dimer‐X)
Number of subjects: 86
Study 1100789 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG, routine laboratory analyses of CSF, neurologic examinations
Number of subjects: 86
Study 30007300 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.018-inch slot orthodontic bracket system
Number of subjects: 187
Study 30007300 — intervention group
Group type: COMPARATOR
Intervention: 0.022-inch slot orthodontic bracket system
Number of subjects: 187
Study 30007300 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 187
Study 28854376 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambient light
Number of subjects: 357
Study 28854376 — intervention group
Group type: COMPARATOR
Intervention: Darkened room
Number of subjects: 357
Study 27021544 — intervention group
Group type: EXPERIMENTAL
Intervention: benzethonium chloride (BZC) gargle
Number of subjects: 29
Study 27021544 — intervention group
Group type: COMPARATOR
Intervention: placebo gargle
Number of subjects: 29
Study 27021544 — intervention group
Group type: COMPARATOR
Intervention: no gargle
Number of subjects: 29
Study 25077855 — intervention group
Group type: EXPERIMENTAL
Intervention: Religious involvement
Number of subjects: 129